Literature DB >> 20161655

Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.

Joshua T Schiffer1, Laith Abu-Raddad, Karen E Mark, Jia Zhu, Stacy Selke, Amalia Magaret, Anna Wald, Lawrence Corey.   

Abstract

Herpes simplex virus-2 (HSV-2) is a sexually transmitted infection that is the leading cause of genital ulcers worldwide. Infection is life long and is characterized by repeated asymptomatic and symptomatic shedding episodes of virus that are initiated when virus is released from neurons into the genital tract. The pattern of HSV-2 release from neurons into the genital tract is poorly understood. We fit a mathematical model of HSV-2 pathogenesis to curves generated from daily quantification of HSV in mucosal swabs performed from patients with herpetic genital ulcers. We used virologic parameters derived from model fitting for stochastic model simulations. These simulations reproduced previously documented estimates for shedding frequency, and herpetic lesion diameter and frequency. The most realistic model output occurred when we assumed minimal amounts of daily neuronal virus introduction. In our simulations, small changes in average total quantity of HSV-2 released from neurons influenced detectable shedding frequency, while changes in frequency of neuronal HSV-2 release had little effect. Frequent HSV-2 shedding episodes in humans are explained by nearly constant release of small numbers of viruses from neurons that terminate in the genital tract.

Entities:  

Mesh:

Year:  2009        PMID: 20161655      PMCID: PMC2818652          DOI: 10.1126/scitranslmed.3000193

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  43 in total

1.  Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.

Authors:  R H Gray; M J Wawer; R Brookmeyer; N K Sewankambo; D Serwadda; F Wabwire-Mangen; T Lutalo; X Li; T vanCott; T C Quinn
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

2.  Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection.

Authors:  Rob J De Boer; Dirk Homann; Alan S Perelson
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

3.  Direct quantitation of rapid elimination of viral antigen-positive lymphocytes by antiviral CD8(+) T cells in vivo.

Authors:  W Barchet; S Oehen; P Klenerman; D Wodarz; G Bocharov; A L Lloyd; M A Nowak; H Hengartner; R M Zinkernagel; S Ehl
Journal:  Eur J Immunol       Date:  2000-05       Impact factor: 5.532

4.  T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?

Authors:  Christine M Posavad; Anna Wald; Nancy Hosken; Meei Li Huang; David M Koelle; Rhoda L Ashley; Lawrence Corey
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

5.  Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.

Authors:  Anna Wald; David Carrell; Michael Remington; Elizabeth Kexel; Judy Zeh; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2002-02-20       Impact factor: 9.079

6.  Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation.

Authors:  S H Chen; D A Garber; P A Schaffer; D M Knipe; D M Coen
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

7.  Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Authors:  A Wald; J Zeh; S Selke; T Warren; A J Ryncarz; R Ashley; J N Krieger; L Corey
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

8.  CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase.

Authors:  Derek D Sloan; George Zahariadis; Christine M Posavad; Nichlos T Pate; Steven J Kussick; Keith R Jerome
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

9.  Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia.

Authors:  Kamal M Khanna; Robert H Bonneau; Paul R Kinchington; Robert L Hendricks
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

10.  Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.

Authors:  Jia Zhu; Florian Hladik; Amanda Woodward; Alexis Klock; Tao Peng; Christine Johnston; Michael Remington; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

View more
  63 in total

1.  Preventing sexually transmitted infections: back to basics.

Authors:  Anne Rompalo
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

2.  Modeling the dynamics of virus shedding into the saliva of Epstein-Barr virus positive individuals.

Authors:  Giao T Huynh; Libin Rong
Journal:  J Theor Biol       Date:  2012-06-07       Impact factor: 2.691

3.  Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.

Authors:  Warren Phipps; Misty Saracino; Amalia Magaret; Stacy Selke; Mike Remington; Meei-Li Huang; Terri Warren; Corey Casper; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2010-12-09       Impact factor: 5.226

4.  Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.

Authors:  Rachel A Bender Ignacio; Tara Perti; Amalia S Magaret; Sharanya Rajagopal; Claire E Stevens; Meei-Li Huang; Stacy Selke; Christine Johnston; Jeanne Marrazzo; Anna Wald
Journal:  J Infect Dis       Date:  2015-06-04       Impact factor: 5.226

5.  Viral kinetics of genital herpes: a molecular probe into host-viral interactions.

Authors:  Thomas C Quinn
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

Review 6.  Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.

Authors:  Joshua T Schiffer; Sami L Gottlieb
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

Review 7.  Herpesvirus latency.

Authors:  Jeffrey I Cohen
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

8.  Numerical schemes for solving and optimizing multiscale models with age of hepatitis C virus dynamics.

Authors:  Vladimir Reinharz; Harel Dahari; Danny Barash
Journal:  Math Biosci       Date:  2018-03-15       Impact factor: 2.144

9.  Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Authors:  Christine Johnston; Jia Zhu; Lichen Jing; Kerry J Laing; Christopher M McClurkan; Alexis Klock; Kurt Diem; Lei Jin; Jeffrey Stanaway; Elizabeth Tronstein; William W Kwok; Meei-Li Huang; Stacy Selke; Youyi Fong; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

10.  Theaflavin-3,3'-digallate and lactic acid combinations reduce herpes simplex virus infectivity.

Authors:  Charles E Isaacs; Weimin Xu
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.